Using fluorescent probes to visualize RNA in cancer cells
Fluorescent gammaPNA Miniprobes for Imaging Telomeric RNA
This study is working on a new way to see a specific type of RNA in cancer cells that use a special method to grow, which could help doctors better understand and treat these cancers.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Carnegie-Mellon University NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10782520 on NIH RePORTER |
What this research studies
This research focuses on developing fluorescent gammaPNA miniprobes to visualize telomeric RNA, specifically TERRA, in cancer cells that utilize an alternative lengthening of telomeres (ALT) for growth. By improving the detection of TERRA, the study aims to provide insights into its role in cancer diagnosis and therapy. The approach involves using high-affinity probes that enhance the brightness of TERRA signals, allowing for better visualization in both fixed tissues and live cells. This could lead to advancements in identifying ALT cancers and developing targeted treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancers that exhibit alternative lengthening of telomeres, particularly those with high levels of TERRA expression.
Not a fit: Patients with cancers that do not utilize the ALT pathway or do not express TERRA may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and therapies for cancers that rely on the ALT pathway.
How similar studies have performed: Other research has shown promise in using fluorescent probes for RNA visualization, suggesting that this approach could be effective.
Where this research is happening
Pittsburgh, United States
- Carnegie-Mellon University — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Armitage, Bruce a. — Carnegie-Mellon University
- Study coordinator: Armitage, Bruce a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.